SIMULPHARMA ApS: Financial statements 2020
CVR: 32832075
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 718,941 and a net result of DKK 36,378 compared with DKK -12,641 the year before. That is a decrease of 20.6% compared with the year before. The profit margin was 5.1%. Equity in the 2020 report amounted to DKK 221,242. The solvency ratio was 90.2%. The company had 1 employee in the financial year.
- Revenue
- DKK 718,941
- Gross Profit
- DKK 718,941
- Profit/Loss
- DKK 36,378
- Equity
- DKK 221,242
- Total Assets
- DKK 245,195
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 719 t. | 719 t. | 36 t. | 221 t. | 1 |
| 2019 | 905 t. | -15 t. | -13 t. | 185 t. | 1 |
| 2018 | 958 t. | 955 t. | 30 t. | 198 t. | 1 |
| 2017 | 988 t. | - | 5 t. | 167 t. | 1 |
| 2016 | - | 1.1 mio. | 107 t. | 163 t. | - |
How creditworthy is SIMULPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
SIMULPHARMA ApS has published its annual report for 2019. Revenue came to DKK 904,904, and the net result was DKK -12,641.
About SIMULPHARMA ApS
SIMULPHARMA ApS was a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company has 1 employee (2018). In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity in the 2024 report amounted to DKK 63,769.